These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23428605)

  • 21. Psychotropic medication use in Australia, 2007 to 2015: Changes in annual incidence, prevalence and treatment exposure.
    Brett J; Karanges EA; Daniels B; Buckley NA; Schneider C; Nassir A; Zoega H; McLachlan AJ; Pearson SA
    Aust N Z J Psychiatry; 2017 Oct; 51(10):990-999. PubMed ID: 28758432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of medicare part D benzodiazepine exclusion on psychotropic use in benzodiazepine users.
    Ong MK; Xu H; Zhang L; Azocar F; Ettner SL
    J Am Geriatr Soc; 2012 Jul; 60(7):1292-7. PubMed ID: 22725849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Utilization of Psychopharmacological Treatment Among Patients With Newly Diagnosed Bipolar Disorder From 2001 to 2010.
    Chang CM; Wu CS; Huang YW; Chau YL; Tsai HJ
    J Clin Psychopharmacol; 2016 Feb; 36(1):32-44. PubMed ID: 26650974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental direct medical expenditures associated with anxiety disorders for the U.S. adult population: evidence from the Medical Expenditure Panel Survey.
    Shirneshan E; Bailey J; Relyea G; Franklin BE; Solomon DK; Brown LM
    J Anxiety Disord; 2013 Oct; 27(7):720-7. PubMed ID: 24135257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Geriatric psychopharmacology.
    Salzman C
    Annu Rev Med; 1985; 36():217-28. PubMed ID: 2859829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of anxiety in the elderly.
    Markovitz PJ
    J Clin Psychiatry; 1993 May; 54 Suppl():64-8. PubMed ID: 8099579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pattern of psychotropic drug use among older adults having a depression or an anxiety disorder: results from the longitudinal ESA study.
    Préville M; Vasiliadis HM; Bossé C; Dionne PA; Voyer P; Brassard J
    Can J Psychiatry; 2011 Jun; 56(6):348-57. PubMed ID: 21756449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychotropic medication use in former ICU patients with mental health problems: A prospective observational follow-up study.
    Janssen DGA; Jonker J; van Dijk D; Heerdink ER; Egberts TCG; Slooter AJC
    J Crit Care; 2020 Oct; 59():112-117. PubMed ID: 32610245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Psychotropic medication use in children and adolescents in an inpatient setting.
    Pejovic-Milovancevic M; Miletic V; Popovic-Deusic S; Draganic-Gajic S; Lecic-Tosevski D; Marotic V
    Psychiatriki; 2011; 22(4):314-9. PubMed ID: 22271844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mood and anxiety disorders and the use of services and psychotropic medication in an immigrant population: findings from the Israel National Health Survey.
    Ponizovsky AM; Grinshpoon A
    Can J Psychiatry; 2009 Jun; 54(6):409-19. PubMed ID: 19527561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prescription drugs and the changing patterns of treatment for mental disorders, 1996-2001.
    Zuvekas SH
    Health Aff (Millwood); 2005; 24(1):195-205. PubMed ID: 15647230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age on the profile of psychotropic users: results from the 2010 National Ambulatory Medical Care Survey.
    Maust DT; Oslin DW; Marcus SC
    J Am Geriatr Soc; 2014 Feb; 62(2):358-64. PubMed ID: 24417590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns and predictors of antipsychotic medication use among the U.S. population: findings from the Medical Expenditure Panel Survey.
    Wang CC; Farley JF
    Res Social Adm Pharm; 2013; 9(3):263-75. PubMed ID: 21272525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overuse of psychotropic medications among children and adolescents with autism spectrum disorders: perspective from a developing country.
    Memari AH; Ziaee V; Beygi S; Moshayedi P; Mirfazeli FS
    Res Dev Disabil; 2012; 33(2):563-9. PubMed ID: 22119705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of patient co-payments on atypical antipsychotic choice in Poland: implications once generic atypicals are available.
    Wladysiuk M; Araszkiewicz A; Godman B; Szabert K; Barbui C; Haycox A
    Appl Health Econ Health Policy; 2011 Mar; 9(2):101-10. PubMed ID: 21271749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevalence of psychiatric disorders in French general practice using the patient health questionnaire: comparison with GP case-recognition and psychotropic medication prescription].
    Norton J; de Roquefeuil G; David M; Boulenger JP; Ritchie K; Mann A
    Encephale; 2009 Dec; 35(6):560-9. PubMed ID: 20004287
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychotropic drug use among people with intellectual disability before and after deinstitutionalization.
    Nøttestad JA; Linaker OM
    J Intellect Disabil Res; 2003 Sep; 47(Pt 6):464-71. PubMed ID: 12919197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of antipsychotic prescriptions among patients with anxiety disorders treated in inpatient and outpatient psychiatric settings.
    Weber SR; Wehr AM; Duchemin AM
    J Affect Disord; 2016 Feb; 191():292-9. PubMed ID: 26688499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Self-medication of anxiety disorders with alcohol and drugs: Results from a nationally representative sample.
    Robinson J; Sareen J; Cox BJ; Bolton J
    J Anxiety Disord; 2009 Jan; 23(1):38-45. PubMed ID: 18571370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trends in treatment of newly treated schizophrenia-spectrum disorder patients in Taiwan from 1999 to 2006.
    Wu CS; Lin YJ; Feng J
    Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):989-96. PubMed ID: 22416032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.